BACKGROUND AND PURPOSE: Infratentorial abnormalities may cause cognitive deficits, but current research criteria for vascular dementia (VaD) do not consider them. Our purposes were to determine the prevalence of infratentorial abnormalities in VaD, their relation with supratentorial abnormalities, and whether they are relevant to cognition. METHODS: We examined 182 patients (120 men, mean age=73 years, SD=8) with probable VaD at inclusion into a multicenter clinical trial. MRI scans were evaluated for infratentorial vascular abnormalities, midbrain atrophy, cerebellar atrophy, basilar artery diameter and tortuosity, and supratentorial abnormalities. Cognitive testing included the mini-mental state examination (MMSE) and the vascular dementia assessment scale (VaDAS-cog). RESULTS: One hundred forty-one (77.5%) patients had infratentorial abnormalities: 119 (65.4%) had focal infratentorial vascular lesions, 65 (35.7%) had diffuse pontine vascular abnormalities hyperintense on T2-weighted images, 20 (11.0%) had midbrain atrophy, and 16 (8.8%) had cerebellar atrophy. Significant correlations were found between number of infratentorial vascular lesions and basilar artery diameter (rs=0.26; P<0.0001), infratentorial and basal ganglia (including thalamus) vascular abnormalities (rs=0.30; P<0.0001), as well as between midbrain atrophy and global supratentorial atrophy (rs=0.27; P<0.0001). Infratentorial vascular abnormalities and cerebellar atrophy were not significantly associated with cognitive impairment. Patients with midbrain atrophy performed worse on cognitive tests than those without midbrain atrophy. After correction for sex, age, education, supratentorial abnormalities, and center, midbrain atrophy remained significantly associated with lower MMSE scores (P<0.05). CONCLUSIONS: Infratentorial abnormalities often occur in patients with VaD, but only midbrain atrophy was found to be relevant to cognition.
BACKGROUND AND PURPOSE:Infratentorial abnormalities may cause cognitive deficits, but current research criteria for vascular dementia (VaD) do not consider them. Our purposes were to determine the prevalence of infratentorial abnormalities in VaD, their relation with supratentorial abnormalities, and whether they are relevant to cognition. METHODS: We examined 182 patients (120 men, mean age=73 years, SD=8) with probable VaD at inclusion into a multicenter clinical trial. MRI scans were evaluated for infratentorial vascular abnormalities, midbrain atrophy, cerebellar atrophy, basilar artery diameter and tortuosity, and supratentorial abnormalities. Cognitive testing included the mini-mental state examination (MMSE) and the vascular dementia assessment scale (VaDAS-cog). RESULTS: One hundred forty-one (77.5%) patients had infratentorial abnormalities: 119 (65.4%) had focal infratentorial vascular lesions, 65 (35.7%) had diffuse pontine vascular abnormalities hyperintense on T2-weighted images, 20 (11.0%) had midbrain atrophy, and 16 (8.8%) had cerebellar atrophy. Significant correlations were found between number of infratentorial vascular lesions and basilar artery diameter (rs=0.26; P<0.0001), infratentorial and basal ganglia (including thalamus) vascular abnormalities (rs=0.30; P<0.0001), as well as between midbrain atrophy and global supratentorial atrophy (rs=0.27; P<0.0001). Infratentorial vascular abnormalities and cerebellar atrophy were not significantly associated with cognitive impairment. Patients with midbrain atrophy performed worse on cognitive tests than those without midbrain atrophy. After correction for sex, age, education, supratentorial abnormalities, and center, midbrain atrophy remained significantly associated with lower MMSE scores (P<0.05). CONCLUSIONS:Infratentorial abnormalities often occur in patients with VaD, but only midbrain atrophy was found to be relevant to cognition.
Authors: Xavier Guell; Sheeba A Anteraper; Satrajit S Ghosh; John D E Gabrieli; Jeremy D Schmahmann Journal: Cerebellum Date: 2020-02 Impact factor: 3.847
Authors: S S Staekenborg; E C W van Straaten; W M van der Flier; R Lane; F Barkhof; P Scheltens Journal: J Neurol Date: 2008-07-18 Impact factor: 4.849
Authors: Xavier Guell; Mathias Goncalves; Jakub R Kaczmarzyk; John D E Gabrieli; Jeremy D Schmahmann; Satrajit S Ghosh Journal: PLoS One Date: 2019-01-16 Impact factor: 3.240
Authors: Maria Del C Valdés Hernández; Tara Grimsley-Moore; Francesca M Chappell; Michael J Thrippleton; Paul A Armitage; Eleni Sakka; Stephen Makin; Joanna M Wardlaw Journal: Front Neurol Date: 2021-03-01 Impact factor: 4.003
Authors: Gene L Bowman; Hiroko H Dodge; Nora Mattek; Aron K Barbey; Lisa C Silbert; Lynne Shinto; Diane B Howieson; Jeffrey A Kaye; Joseph F Quinn Journal: Front Aging Neurosci Date: 2013-12-16 Impact factor: 5.750
Authors: Lei Zhao; Adrian Wong; Yishan Luo; Wenyan Liu; Winnie W C Chu; Jill M Abrigo; Ryan K L Lee; Vincent Mok; Lin Shi Journal: Front Neurosci Date: 2018-05-01 Impact factor: 4.677